Automated Office Blood Pressure Measurement Requires Technology and Implementation.

JAMA network open · August 2022 · Romsai Tony Boonyasai

What this study found

This study examines Automated Office Blood Pressure Measurement Requires Technology and Implementation. Editorial review is required before publishing clinical takeaways.

Open on PubMed DOI

Landmark study

Why this trial matters

USPSTF 2022 statin primary prevention

How RAGMD uses this study

Clinical questions this paper informs

Synthesis lives on the evidence question — this page shows where the study sits in that analysis.

Supporting literature

Should adults take statins for primary cardiovascular prevention?

Meta-analyses of primary prevention trials show reduced major adverse cardiovascular events with statins in appropriately selected moderate-to-high-risk adults. Shared decision-making should weigh absolute risk reduction against side effects and patient preference.

Open evidence analysis

Supporting literature

Does hormone therapy improve metabolic syndrome markers?

Menopausal hormone therapy may favorably affect some metabolic markers in selected women but is not a primary treatment for metabolic syndrome. Lifestyle and cardiometabolic risk management remain foundational.

Open evidence analysis

Supporting literature

Can hormone therapy help insulin resistance in peri- and postmenopausal women?

Some studies show improved insulin sensitivity with estrogen-based therapy in early postmenopause, but results are not uniform across regimens. HRT should not replace evidence-based diabetes prevention or treatment.

Open evidence analysis

Supporting literature

Do omega-3 supplements prevent cardiovascular disease in the general population?

High-dose EPA (icosapent ethyl) reduced events in selected high-risk statin-treated patients in REDUCE-IT. General over-the-counter omega-3 supplements show inconsistent or null benefit in primary prevention populations.

Open evidence analysis

Supporting literature

Should aspirin be used for primary cardiovascular prevention?

Current guidelines generally discourage routine aspirin for primary prevention in low-to-moderate-risk adults because bleeding harm offsets modest benefit. Select high-risk individuals may still be considered with shared decision-making.

Open evidence analysis

Read the evidence analysis Research library